TraceLink's Roddy Martin interviews senior pharmaceutical supply chain executive Peter Bigelow, President of xCell Strategic Consulting, on the critical role CDMOs play in the pursuit of supply chain agility.Key TakeawaysSupply chain has moved from a concept to a discipline, bringing more science and process to the industry.Over the last three years, about 50% of new drugs have been launched through CDMOs, underscoring their importance to the industry. For CDMOs, quality is the number one consideration, followed by innovation and investments.

Ver todos los episodios